Mechanistic Insights into the Neurotoxicity of 2,5-Dimethoxyphenethylamines (2C) and Corresponding N-(2-methoxybenzyl)phenethylamine (NBOMe) Drugs.
Eva Gil-Martins, Fernando Cagide-Fagín, Daniel Martins, Ana Borer, Daniel José Barbosa, Carlos Fernandes, Daniel Chavarria, Fernando Remião, Fernanda Borges, Renata Silva
Journal of Xenobiotics June 5, 2024 DOI: 10.3390/jox14020044 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | In vitro study Peer reviewed |
|---|---|
| Population | Differentiated SH-SY5Y cells and primary rat cortical cultures |
| Interventions | 2C-T-2 2C-T-4 2C-T-7 25T7-NBOMe |
| Dose | 0-1000 μM |
| Keywords | 2c drugs Nbome drugs New psychoactive substances Substituted phenethylamines Neurotoxicity mechanisms Drug neurotoxicity Cellular neurotoxicity Toxic cellular effects Harmful cellular effects Mitochondrial dysfunction Calcium disruption Designer drugs Synthetic drugs Novel psychoactive substances Emerging drugs Phenethylamine derivatives Synthetic phenethylamines Drug toxicity research Drug safety studies Toxicology research Cell model studies |
| Citations | 2 |
| Key points | NBOMe drugs were more cytotoxic than their 2C counterparts, with toxicity linked to mitochondrial dysfunction, ATP depletion, and calcium imbalance. |
Abstract
Substituted phenethylamines including 2C (2,5-dimethoxyphenethylamines) and NBOMe (N-(2-methoxybenzyl)phenethylamines) drugs are potent psychoactive substances with little to no knowledge available on their toxicity. In the present in vitro study, we explored the mechanisms underlying the neurotoxicity of six substituted phenethylamines: 2C-T-2, 2C-T-4, 2C-T-7 and their corresponding NBOMes. These drugs were synthesized and chemically characterized, and their cytotoxicity (0-1000 μM) was evaluated in differentiated SH-SY5Y cells and primary rat cortical cultures, by the NR uptake and MTT reduction assays. In differentiated SH-SY5Y cells, mitochondrial membrane potential, intracellular ATP and calcium levels, reactive oxygen species production, and intracellular total glutathione levels were also evaluated. All the tested drugs exhibited concentration-dependent cytotoxic effects towards differentiated SH-SY5Y cells and primary rat cortical cultures. The NBOMe drugs presented higher cytotoxicity than their counterparts, which correlates with the drug's lipophilicity. These cytotoxic effects were associated with mitochondrial dysfunction, evident through mitochondrial membrane depolarization and lowered intracellular ATP levels. Intracellular calcium imbalance was observed for 2C-T-7 and 25T7-NBOMe, implying a disrupted calcium regulation. Although reactive species levels remained unchanged, a reduction in intracellular total GSH content was observed. Overall, these findings contribute to a deeper understanding of these drugs, shedding light on the mechanisms underpinning their neurotoxicity.
Citations in the library
Cited by 2
- The role of mitochondrial dysfunction and calcium dysregulation in 2C-I and 25I-NBOMe-induced neurotoxicity. Chemico-Biological Interactions April 25, 2025
- Sublethal Concentrations of 2C-I and 25I-NBOMe Designer Drugs Impact Caenorhabditis elegans Development and Reproductive Behavior. International Journal of Molecular Sciences March 26, 2025
Cites 15
- Receptor interaction profiles of novel N-2-methoxybenzyl (NBOMe) derivatives of 2,5-dimethoxy-substituted phenethylamines (2C drugs). Neuropharmacology December 1, 2015
- The promises and perils of psychedelic pharmacology for psychiatry. Nature Reviews Drug Discovery June 1, 2022
- Psychedelics. Current Biology 2022
- A brief history of ‘new psychoactive substances’ Drug Testing and Analysis July 1, 2011
- Psychedelic-inspired approaches for treating neurodegenerative disorders. Journal of Neurochemistry July 1, 2022
and 10 more in the library